Interleukin 10 Level in the Cerebrospinal Fluid as a Possible Biomarker for Lymphomatosis Cerebri

  • Hashiguchi Shunta
    Department of Neurology, Yokohama City University Medical Center, Japan
  • Momoo Takayuki
    Department of Neurology, Yokohama City University Medical Center, Japan
  • Murohashi Yoko
    Department of Neurology, Yokohama City University Medical Center, Japan
  • Endo Masanao
    Department of Neurology, Yokohama City University Medical Center, Japan
  • Shimamura Megumi
    Department of Neurology, Yokohama City University Medical Center, Japan
  • Kawasaki Takashi
    Department of Neurosurgery, Yokohama City University Medical Center, Japan
  • Kanada Sachie
    Department of Pathology, Yokohama City University Medical Center, Japan
  • Nozawa Akinori
    Department of Pathology, Yokohama City University Medical Center, Japan
  • Tada Mikiko
    Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan
  • Koyano Shigeru
    Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan
  • Tanaka Fumiaki
    Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan

この論文をさがす

抄録

A 71-year-old immunocompetent man developed cognitive decline and gait disturbance. Brain magnetic resonance imaging (MRI) revealed bilateral diffuse leukoencephalopathy without a mass lesion. An analysis of the cerebrospinal fluid (CSF) showed elevated levels of interleukin (IL)-10. The condition of the patient progressively deteriorated, and intravenous high-dose steroids proved ineffective. Detection of non-destructive, diffusely infiltrating, large B-cell lymphoma in biopsy and autopsy specimens led to a diagnosis of lymphomatosis cerebri (LC). On serial MRI, the basal ganglia and white matter lesions increased in parallel with the levels of IL-10. These findings suggest that the IL-10 level in the CSF may represent a potentially useful biomarker for the early diagnosis and monitoring of the disease progression in LC.<br>

収録刊行物

  • Internal Medicine

    Internal Medicine 54 (12), 1547-1552, 2015

    一般社団法人 日本内科学会

被引用文献 (3)*注記

もっと見る

参考文献 (20)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ